Issue Navigation
-
Review
-
54-61
Development of mitochondrial permeability transition inhibitory agents: a novel drug target.
Hellebrand EE, Varbiro G
Drug Discov Ther. 2010; 4(2):54-61.
-
62-69
Uses of single-particle tracking in living cells.
Zhou X, Wang L
Drug Discov Ther. 2010; 4(2):62-69.
-
70-76
Shah MR, Sancheti PP, Vyas VM, Karekar PS, Pore YV
Drug Discov Ther. 2010; 4(2):70-76.
-
77-84
Enhancement of the dissolution profile of allopurinol by a solid dispersion technique.
Samy AM, Marzouk MA, Ammar AA, Ahmed MK
Drug Discov Ther. 2010; 4(2):77-84.
-
85-92
Nouh AT, Abd El-Gawad AH, Guda TK
Drug Discov Ther. 2010; 4(2):85-92.
-
93-99
Nouh AT, Abd El-Gawad AH, Guda TK
Drug Discov Ther. 2010; 4(2):93-99.
-
100-108
Biopharmaceutical evaluation of formulated metformin/rosiglitazone tablets.
Ibrahim HK, Attia AM, Ghorab MM
Drug Discov Ther. 2010; 4(2):100-108.
-
109-122
Calcium alginate cross-linked polymeric microbeads for oral sustained drug delivery in arthritis.
Manjanna KM, Pramod Kumar TM, Shivakumar B
Drug Discov Ther. 2010; 4(2):109-122.
-
123-128
Effects of lubricants on binary direct compression mixtures.
Uğurlu T, Halaçoğlu MD, Türkoğlu M
Drug Discov Ther. 2010; 4(2):123-128.
-
129-134
Hirotani Y, Ikeda K, Myotoku M
Drug Discov Ther. 2010; 4(2):129-134.
-
135-143
Miyauchi M, Murata M, Shibuya K, Koga-Yamakawa E, Yanagawa Y, Azuma I, Kashiwazaki Y
Drug Discov Ther. 2010; 4(2):135-143.